Arokianathan et al 30 | Assimakopoulos et al 31 | Kahn et al 32 | Liao et al 33 | Ludwig et al 34 | Cantwell et al 35 | Umei et al 36 | Jukkkaphop C et al (this case) | ||||
Age (year) | 30 | 28 | 57 | 80 | 58 | N/A | 32 | 34 | 39 | 50 | 39 |
Gender | Male | Male | Male | Male | Male | Male | Male | Male | Male | Male | Male |
Comorbidity | None | None | None | HT, AF, T2DM, HF | Ulcerative colitis, T2DM | N/A | None | None | Obesity | None | None |
Presentation | 4 days of myalgia, jaundice | 2 days of fever, headache, dyspnoea and haemoptysis | 10 days of fever, haemoptysis, jaundice, AKI | 2 days of fever, myalgia, haemoptysis and AKI, | 4 days of fever, myalgias, non-bloody diarrhoea and AKI | Flu-like symptom | 2 days of fever, myalgia and jaundice | 7 days of fatigue and vomiting, and presentation with dyspnoea, jaundice and AKI | Fever, myalgia, headache, progressive dyspnoea and AKI | 2 days of fever, myalgia and jaundice | 5 days of fever, myalgia; 6 hours of dyspnoea and haemoptysis |
Haemoptysis | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
PaO2/FiO2ratio | N/A | 210 | 200 | 90 | 150 | N/A | 163 | N/A | 131 | 70 | 74.2 |
Treatment | MV MARS | MV | MV RRT | MV RRT | MV RRT | MV RRT | MV | MV Plasmapheresis RRT | MV | MV RRT | MV Plasmapheresis |
ECMO Initiate day | VV-ECMO 183 hours | Not done | Not done | Not done | Not done | VA-ECMO 60 hours | VV-ECMO, 1 day and total of 6 days | VV-ECMO, 1 day | VV-ECMO, 2 days after admission, double membrane oxygenator, in parallel | VV-ECMO, 3 days after admission, (day 5 after symptom) | VV-ECMO, 12 hours and total of 8 days |
Outcome | Improved | Improved | Improved | Improved | Dead (multiorgan failure) | Improved | Improved | Dead, 29 hours after initial presentation (multiorgan failure) | Improved | Improved | Improved |
AF, atrial fibrillation; AKI, acute kidney injury; ECMO, extracorporeal membrane oxygenation; HF, heart failure; HT, hypertension; MARS, molecular adsorbent recirculating system; MV, mechanical ventilator;N/A, not available; RRT, renal replacement therapy; T2DM, type 2 diabetes mellitus; VA-ECMO, veno-arterial extracorporeal membrane oxygenation.